Paris, France - We are proud to announce the successful completion of our ISO 27001 and Health Data Hosting (HDS) certification audits. This dual achievement positions our company as a trusted, compliant partner in the highly regulated healthcare and pharmaceutical sectors.
Why These Certifications Matter: Building Trust Through Certification
Obtaining ISO 27001 and HDS certifications represents more than regulatory compliance. It's a strategic foundation that enables us to handle the most sensitive health data with the highest standards of security and confidentiality.
What is ISO 27001 Certification?
ISO 27001 is the internationally recognized standard for information security management. It demonstrates that an organization has implemented robust processes to protect data, manage risks, and ensure continuous improvement in security practices. For pharmaceutical and healthcare partners worldwide, ISO 27001 certification serves as a seal of quality and reliability.
What is HDS Certification?
Health Data Hosting (Hébergeur de Données de Santé) certification is a French regulatory requirement for organizations that host health data. HDS certification is essential for working with major hospital groups, national health agencies and public healthcare institutions in France. It ensures GDPR compliance and demonstrates the highest standards of health data protection.
What These Certifications Mean for Our Partners
Streamlined Security Audits and Due Diligence
For current and future partners, these certifications guarantee security and compliance, streamlining audits and reducing the complexity of security due diligence processes. Hospital groups, pharmaceutical companies and research institutions can confidently collaborate with us, knowing their sensitive data is protected according to international standards.
Access to Major Healthcare and Pharmaceutical Partnerships
HDS certification is a prerequisite for participating in large public and private hospital tenders and partnerships with national health agencies. ISO 27001 opens doors to pharmaceutical collaborations and facilitates the integration of our products and services into large-scale research and development projects.
Strengthened Market Position in Healthcare Data
These certifications strengthen our position as a reliable partner in the oncology and health data ecosystem. We now hold a sustainable competitive advantage, particularly in French and European markets, with ISO 27001 serving as a credibility accelerator for international expansion wherever GDPR regulations apply.
Recognized as Research Sponsor and Health Data Platform
We are now officially recognized with three distinct designations: scientific research sponsor, software publisher and hosting platform for health applications and data. This triple recognition reflects the breadth of our capabilities and our commitment to supporting every stage of the healthcare research journey.
A Collective Achievement
The certification process, which spanned over a year, was a true team effort led by key members of our compliance and engineering teams:
Anne Thomsen, Head of Legal & Data Protection Officer
Louis-Baptiste, Head of Engineering & Chief Information Security Officer
Damien Leger, Lead DevSecOps
Marine Otero del Val, Head of Product
Léa Vandenhaute, Data Protection Lawyer
Victoria Rutman, Quality & Compliance Manager
Supported by consulting firm Feel Agile, this collective effort demonstrated what happens when teams align around a shared mission. "This certification is far more than a compliance achievement. It is a strategic foundation for our future," said Victoria Rutman, Quality & Compliance Manager. "It reinforces the trust of our partners, accelerates our development in the pharmaceutical sector and supports our expansion."
Our Commitment to Excellence
What makes this achievement particularly noteworthy is our age as a company. It is rare for such a young organization to obtain HDS certification, demonstrating our commitment to operational excellence from our earliest stages.
The certification process revealed our culture of excellence, our dedication to advancing oncology research with robust operational standards, and our cross-functional collaboration capabilities. The documentation and processes implemented have brought clarity and operational efficiency while ensuring that we combine both performance and robustness.
Maintaining Our Commitment to Information Security
With certifications in hand, our focus now shifts to maintaining and enhancing these high standards. We have embedded a culture of information security and compliance, with continuous improvement at the core of our operations.
As we continue to advance our Rosalind Study platform and expand our partnerships in oncology research, these certifications provide the trusted foundation necessary for handling sensitive health data and scaling operations responsibly.
About Us
Cure51 is a French techbio company dedicated to advancing oncology research through technology solutions. By combining software expertise with rigorous data security standards, we enable research progress while maintaining the highest levels of data protection and regulatory compliance.
Updated: February 18, 2026
